Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-19

FDA Approved: DICLOFENAC SODIUM MISOPROSTOL — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for diclofenac sodium and misoprostol, a generic diclofenac/misoprostol combination product manufactured by Nivagen Pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac sodium and misoprostol (diclofenac sodium and misoprostol)

Snippet

ORIG AP for DICLOFENAC SODIUM MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)